MarketCap
Facebook
X
TelegramAnnual report 2022
added 12-21-2024
Country |
 China |
IPO year |
2020 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
- |
Market Cap[1] |
$ 80.1 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Biomerica
BMRA
|
$ 2.19 | 5.29 % | $ 5.03 M | Nasdaq Capital Market |  USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Brainsway Ltd.
BWAY
|
$ 13.66 | -1.94 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
 |
Castle Biosciences
CSTL
|
$ 25.0 | -2.72 % | $ 694 M | Nasdaq Global Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Quest Diagnostics Incorporated
DGX
|
$ 195.26 | 0.57 % | $ 21.7 B | NYSE,SPB | USA |
 |
DexCom
DXCM
|
$ 66.95 | -0.48 % | $ 26.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 104.91 | 0.95 % | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 15.51 | -0.32 % | $ 469 M | Nasdaq Global Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
ICON Public Limited Company
ICLR
|
$ 99.7 | 1.68 % | $ 8.22 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.7 | 3.03 % | $ 7.46 M | Nasdaq Global Select Market | USA |
 |
IDEXX Laboratories
IDXX
|
$ 577.26 | -0.45 % | $ 46.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 124.33 | -1.79 % | $ 19.8 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 166.07 | -0.24 % | $ 28.5 B | NYSE,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Lantheus Holdings
LNTH
|
$ 76.43 | -2.0 % | $ 5.16 B | Nasdaq Global Select Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 452.51 | -1.82 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 153.6 | 0.36 % | $ 7.61 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Mettler-Toledo International
MTD
|
$ 1 204.48 | 1.18 % | $ 24.8 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 4.58 | -3.78 % | $ 424 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 3.45 | 5.83 % | $ 1.85 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 7.96 | -2.69 % | $ 1.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
National Research Corporation
NRC
|
$ 17.32 | 0.06 % | $ 388 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 195.28 | -3.67 % | $ 19.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.15 | 2.68 % | $ 1.46 M | Nasdaq Capital Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 189.35 | -0.4 % | $ 135 B | NYSE,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.12 | -4.27 % | $ 777 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 111.3 | -0.39 % | $ 33.8 B | NYSE,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 7.99 | -3.03 % | $ 31.8 M | Nasdaq Capital Market | Israel |
 |
Guardant Health
GH
|
$ 85.18 | -4.38 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Precipio
PRPO
|
$ 27.88 | 3.53 % | $ 36.2 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 7.26 | 0.97 % | $ 430 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
|
Biodesix
BDSX
|
$ 14.88 | -8.74 % | $ 1.93 B | Nasdaq Global Market | USA |
 |
RadNet
RDNT
|
$ 61.49 | -1.84 % | $ 4.62 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 17.15 | -2.5 % | $ 914 M | Nasdaq Global Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.